SAFFRON HEALTH PARTNERSHIP — All Prescriptions & Medications — Page 4
Practice Code: E81057 | BIGGLESWADE, SG18 8DJ
Showing results 151-200 of 718
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Bumetanide | 518 | 28.4K | £2.7K | +90.1% ▲ |
| Semaglutide | 514 | 9,852 | £39.0K | +113.5% ▲ |
| Aciclovir | 510 | 45.6K | £8.0K | +242.9% ▲ |
| Pramipexole | 508 | 24.1K | £3.9K | +417.4% ▲ |
| Trazodone hydrochloride | 507 | 29.1K | £1.5K | +148.1% ▲ |
| Letrozole | 507 | 14.2K | £1.3K | +171.5% ▲ |
| Methocarbamol | 491 | 56.8K | £3.6K | +925.8% ▲ |
| Clobetasone butyrate | 484 | 20.6K | £4.3K | +137.1% ▲ |
| Baclofen | 483 | 64.2K | £1.6K | +141.1% ▲ |
| Estradiol | 481 | 10.8K | £5.4K | +78.3% ▲ |
| Oxycodone hydrochloride | 478 | 46.6K | £11.2K | +86.8% ▲ |
| Hyoscine butylbromide | 474 | 45.6K | £3.1K | +103.4% ▲ |
| Cetirizine hydrochloride | 467 | 41.9K | £2.5K | -6.5% ▼ |
| Timolol and bimatoprost | 464 | 5,643 | £6.9K | +205.7% ▲ |
| Azathioprine | 459 | 25.2K | £616 | +323.5% ▲ |
| Bimatoprost | 454 | 3,933 | £3.5K | +205.4% ▲ |
| Clobetasol propionate | 453 | 26.0K | £2.1K | +232.0% ▲ |
| Clarithromycin | 446 | 12.5K | £2.1K | +81.8% ▲ |
| Cyclizine hydrochloride | 440 | 23.0K | £854 | +172.8% ▲ |
| Fluticasone/umeclidinium/vilanterol | 439 | 439 | £18.5K | +87.3% ▲ |
| Risedronate sodium | 431 | 1,724 | £455 | +255.3% ▲ |
| 430 | 46.2K | £1.5K | +55.5% ▲ | |
| Lymecycline | 423 | 13.3K | £1.5K | +251.7% ▲ |
| Prochlorperazine maleate | 422 | 19.2K | £1.2K | +108.8% ▲ |
| Mometasone furoate | 418 | 24.1K | £2.5K | +212.6% ▲ |
| Acetylcysteine | 411 | 11.8K | £2.0K | +474.9% ▲ |
| Dorzolamide and timolol | 411 | 9,235 | £5.7K | +187.2% ▲ |
| Nefopam hydrochloride | 409 | 36.6K | £1.6K | +261.6% ▲ |
| Tolterodine | 404 | 16.4K | £1.9K | +171.7% ▲ |
| Timolol | 404 | 9,005 | £2.4K | +356.8% ▲ |
| Canagliflozin | 399 | 13.4K | £16.5K | +177.9% ▲ |
| 396 | 100.5K | £2.2K | +50.1% ▲ | |
| Oxybutynin | 387 | 20.5K | £2.9K | +103.2% ▲ |
| Etoricoxib | 385 | 11.2K | £2.5K | +377.8% ▲ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 384 | 388 | £17.1K | +129.6% ▲ |
| Ispaghula husk | 380 | 17.0K | £3.0K | +188.5% ▲ |
| Cefalexin | 378 | 12.9K | £1.0K | +225.0% ▲ |
| Docusate sodium | 375 | 51.7K | £3.7K | +1.1% vs avg |
| Pizotifen malate | 369 | 15.5K | £682 | +347.7% ▲ |
| Enalapril maleate | 368 | 11.9K | £571 | +104.8% ▲ |
| Lisdexamfetamine dimesylate | 368 | 9,699 | £24.3K | +208.2% ▲ |
| Calcipotriol | 361 | 25.9K | £13.1K | +112.1% ▲ |
| Moxonidine | 360 | 16.0K | £2.4K | +546.7% ▲ |
| Diclofenac diethyl | 354 | 38.4K | £2.5K | -0.3% vs avg |
| Azithromycin | 350 | 8,787 | £2.5K | +176.1% ▲ |
| Insulin detemir | 344 | 2,008 | £16.8K | +339.2% ▲ |
| Meloxicam | 343 | 11.1K | £327 | +418.6% ▲ |
| Lorazepam | 342 | 13.0K | £2.6K | +139.9% ▲ |
| Nifedipine | 339 | 15.0K | £2.5K | +80.9% ▲ |
| Fusidic acid | 338 | 6,510 | £828 | +164.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.